URS

Grand Chess Tour Names 2024 Field of Elite Players to Compete for $1.5 Million Purse

Retrieved on: 
Thursday, February 22, 2024
Entertainment, Sports, Other Entertainment, Other Sports, General Entertainment, Electronic Games, Education, Grand Chess Tour, Grand Chess, Health, COVID-19, URS, FIDE, Saint Louis Chess Club, Partnership

Three players qualified by finishing 1st through 3rd in the 2022 Grand Chess Tour.

Key Points: 
  • Three players qualified by finishing 1st through 3rd in the 2022 Grand Chess Tour.
  • The prize fund is provided by the 2024 Grand Chess Tour major sponsors Superbet Foundation and The Saint Louis Chess Club , both non-profit organizations that support chess education and the mission to expand the game of chess to a worldwide audience.
  • Grand Chess Tour is a circuit of international events, each demonstrating the highest level of organization for the world's best players.
  • The legendary Garry Kasparov, one of the world's greatest ambassadors for chess, inspired the Grand Chess Tour and helped solidify the partnership between the organizers.

UroGen Pharma Reports Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, November 14, 2023
Biotechnology, Pharmaceutical, Health, Oncology, NDA, Medicine, Webcast, Rated R, NMIBC, RTW, Chemistry, Risk, TURBT, Patient, Investment, Probability, Research, Carcinoma, LG, FDA, Mitomycins, Conference, ATLAS, Software, Death, CMC, Nephrectomy, Growth, CRR, Recurrence, URS, Role, Pharmaceutical industry, Medical imaging, Dietary supplement, Video game, Agency

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced financial results for the third quarter ended September 30, 2023, and provided an overview of recent developments.

Key Points: 
  • UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced financial results for the third quarter ended September 30, 2023, and provided an overview of recent developments.
  • “During the third quarter, UroGen achieved several notable milestones, including announcement of unprecedented positive results from our ENVISION and ATLAS Phase 3 trials of UGN-102 in LG-IR-NMIBC,” said Liz Barrett, President, and Chief Executive Officer of UroGen.
  • Activated sites on November 1, 2023 were 1,088, compared to 1,058 on August 1, 2023, while repeat accounts on November 1, 2023 were 296, compared to 267 on August 1, 2023.
  • Third Quarter 2023 Financial Results:
    JELMYTO Revenue: UroGen reported net product revenue of JELMYTO for the third quarter 2023 of $20.9 million, compared to $16.1 million in the third quarter of 2022.

Increasing Incidence of Kidney Stone Disease Drives Growth in Stone Management Disposables Market, with Calcium Oxalate Stones Dominating - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 8, 2023
General Health, Pharmaceutical, Health, Surgery, Kidney stone disease, Cysteine, Ureteroscopy, Uric acid, Struvite, Epidemiology, Incidence, Region, URS, Internet, Urology, Country, Calcium oxalate, ASP, Abdomen, Kidney, Groin, Disease, Urine, COVID-19, SWOT, Segment, Market access, Forecast, PCNL, Blood, Nephrology, SWL, Woman, Pain, Patient, SWOT analysis, System, Retail, Health care

The model discusses in detail the impact of COVID-19 on Stone Management Disposables market for the year 2020 and beyond.

Key Points: 
  • The model discusses in detail the impact of COVID-19 on Stone Management Disposables market for the year 2020 and beyond.
  • Nephrolithiasis, or kidney stone disease, is a condition in which individuals form stones in the kidney or urinary tract.
  • Kidney stones can be classified based on their chemical composition: calcium oxalate, calcium phosphate, uric acid, cysteine, struvite.
  • Calcium oxalate stones are the most commonly formed stones and account for approximately 82% of stone cases.

Marchex Hires Holly Aglio as Chief Financial Officer

Retrieved on: 
Tuesday, October 31, 2023
Professional Services, Data Management, Business, Technology, Software, Artificial Intelligence, Cerberus, Intelligence, PwC, URS, Financial management, Cerberus Capital Management, Organization, Acquisition, Holly, NetCentrics, Growth, Investment, Aglio, Management, Marchex

Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced that Holly Aglio has joined the company as Chief Financial Officer.

Key Points: 
  • Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced that Holly Aglio has joined the company as Chief Financial Officer.
  • Aglio is a seasoned financial leader, having served in multiple influential financial management roles during her career, and will lead Marchex’s finance and accounting organizations.
  • Most recently, from 2021 to 2023 Aglio was Chief Financial Officer and a member of the Board of Directors of NetCentrics, a technology business supporting national security, and led its 2021 acquisition by Cerberus Capital Management.
  • At NetCentrics, Aglio played a pivotal role in accelerating the company’s growth through strategic financial management and investments in key capabilities.

Ultimate Risk Solutions (URS) announces fully automated one-click Schedule-P reporting solution in its loss reserving software, Res-Solver™

Retrieved on: 
Tuesday, October 24, 2023
Consulting, Data Management, Banking, Accounting, Technology, Professional Services, Data Analytics, Software, Fintech, Insurance, Finance, Risk, Entrepreneurship, URS, Multimedia, Risk management

Ultimate Risk Solutions (URS) has implemented a one-click solution to produce all Schedule-P reports in its loss reserving software, Res-Solver™.

Key Points: 
  • Ultimate Risk Solutions (URS) has implemented a one-click solution to produce all Schedule-P reports in its loss reserving software, Res-Solver™.
  • This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20231024201638/en/
    Ultimate Risk Solutions (URS) announces fully automated one-click Schedule-P reporting solution in its loss reserving software, Res-Solver (Graphic: Business Wire)
    “Every US insurance company needs to estimate its loss reserves and to produce Schedule-P reports, tasks that take considerable time, effort, and expense,” said Alex Bushel, Founder and President of URS.
  • “With this new solution, the journey from loss data to Schedule-P reports should now be fast and seamless for reserving actuaries.”

Unissant Welcomes Craig Janus as Chief Strategy and Revenue Officer

Retrieved on: 
Tuesday, September 12, 2023
Janus, Marine Corps Expeditionary Medal, Special Olympics, TAG, SAIC, MS, URS, Indian Olympic Association, Washington Adventist University, Johns Hopkins University, Telecommunications, Knowledge, Growth, Noblis, Health, Pharmaceutical industry, Management, Business

HERNDON, Va., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Unissant, an industry leader in data and advanced analytics solutions for health and national security, today announced Craig Janus as Chief Strategy and Revenue Officer.

Key Points: 
  • HERNDON, Va., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Unissant, an industry leader in data and advanced analytics solutions for health and national security, today announced Craig Janus as Chief Strategy and Revenue Officer.
  • In this newly created role, Janus will oversee all corporate strategy, development and growth initiatives to further strengthen and expand Unissant’s footprint in the federal healthcare and national security markets.
  • “We are excited to welcome Craig as a senior member of the leadership team here at Unissant,” stated Manish Malhotra, CEO of Unissant.
  • “As a seasoned business leader, Craig brings a wealth of knowledge and a proven track record of success with mid-market government contracting businesses.

UroGen Pharma Reports Record JELMYTO Quarterly Sales and Recent Corporate Developments

Retrieved on: 
Thursday, August 10, 2023
Biotechnology, Pharmaceutical, Health, Oncology, Database, Biopsy, Investment, Software, Nephrectomy, NDA, RDF, Rated R, Mitomycins, URS, Journal, Patient, Risk, RTW, Webcast, Growth, LG, Research, Urology, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Recurrence, Death, Food, Conference, The Journal of Urology, ATLAS, Pharmaceutical industry, Video game, Security (finance), Bank, TURBT

“We are in a transformative period for UroGen,” said Liz Barrett, President and Chief Executive Officer of UroGen Pharma.

Key Points: 
  • “We are in a transformative period for UroGen,” said Liz Barrett, President and Chief Executive Officer of UroGen Pharma.
  • UroGen hosted an event to discuss and highlight topline results from the Phase 3 ATLAS and ENVISION clinical trials on July 27th, 2023.
  • Generated record quarterly net product revenue of $21.1 million for the second quarter of 2023, representing ~27% growth over the second quarter of 2022.
  • The rate applied to cash payments incurred in 2023 is 13% based on global net product sales of JELMYTO in 2022.

Essential Utilities’ Aqua Ohio Subsidiary Acquires Union Rome Sewer System

Retrieved on: 
Monday, July 10, 2023
Energy, Natural Resources, Utilities, Other Natural Resources, Employment, Essential, Aqua, URS, Acquisition, Collection, WTRG, Water, Essential Utilities, Growth, Health, NYSE, Safety, Plumbing, County

Essential Utilities Inc. (NYSE: WTRG) today announced its Aqua Ohio subsidiary completed the purchase of the Union Rome Sewer (URS) system for $25.5 million.

Key Points: 
  • Essential Utilities Inc. (NYSE: WTRG) today announced its Aqua Ohio subsidiary completed the purchase of the Union Rome Sewer (URS) system for $25.5 million.
  • The system includes a wastewater collection network and treatment plant serving 5,300 connections in Lawrence County, Ohio.
  • “I’m thankful Aqua is willing to take on improving the system,” said Lawrence County Commissioner Dr. Colton Copely.
  • “The Union Rome Sewer district is $20 million in debt and needs another $12 million in immediate upgrades.

Retrospective Study Finds JELMYTO® Use Effective Following Partial Ablation or Biopsy in Larger Volume Low-Grade Upper Tract Urothelial Tumors that Impede Kidney Preservation

Retrieved on: 
Monday, July 10, 2023
Science, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Clinical Trials, Neoplasm, Nephrectomy, RDF, Associate, Mitomycins, URS, UTUC, Patient, Role, Biopsy, Pharmaceutical industry, Medical imaging, Nursing, Urology

This study assessed the efficacy of JELMYTO in managing patients with larger volume disease where initial tumor burden may not be amenable to complete mechanical ablation or renal preservation.

Key Points: 
  • This study assessed the efficacy of JELMYTO in managing patients with larger volume disease where initial tumor burden may not be amenable to complete mechanical ablation or renal preservation.
  • The goal of this study was to explore alternatives to nephroureterectomy for patients with higher-volume low-grade disease to preserve kidney function and minimize complications.
  • This study aimed to determine if higher volume, low-grade upper tract urothelial tumors (LG-UTUC) patients could achieve disease-free status by undergoing partial ablation or biopsy only before treatment with JELMYTO during the initial ureteroscopy (URS) procedure.
  • Among the 112 renal units evaluated, 50 underwent complete ablation, 42 underwent partial ablation and 20 underwent biopsy only.

David Sullivan Named Senior Vice President of Business Development for THTBC

Retrieved on: 
Thursday, June 15, 2023
Sullivan, Science, Business development, University, Senate, Senior, Mantech, Dan Sullivan (U.S. senator), Lobbying, Northrop, Grumman, David G. Booth, Government, URS, BAE Systems, Growth, George Washington University, Randolph–Macon College, Management, Verizon Communications

FAIRFAX, Va., June 15, 2023 /PRNewswire/ -- Tlingit Haida Tribal Business Corporation | KIRA (THTBC) announced today that David Sullivan has been named Senior Vice President of Business Development.

Key Points: 
  • FAIRFAX, Va., June 15, 2023 /PRNewswire/ -- Tlingit Haida Tribal Business Corporation | KIRA (THTBC) announced today that David Sullivan has been named Senior Vice President of Business Development.
  • He also co-owned a business development consulting company for 14 years, supporting the growth of government contractors ranging from 8(a) to Fortune 100 companies.
  • Across his career, Sullivan has established himself as a seasoned business development and capture management executive with a proven track record in pursuing and winning awards.
  • Prior to his career in business development, Sullivan worked in the U.S. Senate and managed Government Relations for a division of Bell Atlantic (now Verizon).